Know Cancer

or
forgot password

Phase 4 of Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep


Phase 4
18 Years
80 Years
Open (Enrolling)
Both
Colorectal Cancer

Thank you

Trial Information

Phase 4 of Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep


Study is the purpose of evaluating patient satisfaction and at the same time efficacy of the
bowel regimen in cleansing the colon


Inclusion Criteria:



- outpatient colonoscopy for screening for other Gi related problems

Exclusion Criteria:

- Severe CHF,

- CKD,

- less than age 18 or more than 80 years

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Screening

Outcome Measure:

bowel prep efficacy

Outcome Description:

To assess the bowel prep efficacy in cleansing the colon for colonoscopy

Outcome Time Frame:

8 months

Safety Issue:

No

Principal Investigator

Maqsood A Khan, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Rush University Medical Center

Authority:

United States: Institutional Review Board

Study ID:

11042705

NCT ID:

NCT01695863

Start Date:

February 2012

Completion Date:

June 2013

Related Keywords:

  • Colorectal Cancer
  • Miralax with gatorade and dulcolax
  • Movi pre
  • Patient satisfaction and efficacy
  • Colorectal Neoplasms

Name

Location
Rush Unversity Medical Center Chicago, Illinois  60612